Could hookworm saliva lead to a new treatment for type 2 diabetes? 15 September 2021 Sometimes medical breakthroughs appear in the most unexpected forms and that’s why researchers are hopeful that the humble hookworm could hold the key to a new diabetes treatment. Researchers at James Cook University and Macrobiome Therapeutics believe the anti-inflammatory properties of the creature’s saliva may help prevent or delay the development of type 2 diabetes. “If the project is successful and we come up with a drug [for diabetes] inspired by parasitic worms … that will be a game changer, ” molecular parasitologist Dr Alex Loukas said. Studies in developing countries found that people who took deworming medication to remove parasites became more susceptible to conditions like diabetes. “Parasitic worms secrete all sorts of compounds that have anti-inflammatory properties to stop your immune system from flushing [the worms] out,” he said. Hookworms are also being studied for other purposes, such as using their larvae to treat gluten intolerance and coeliac disease, and genetically modifying hookworms to protect frontline soldiers from chemical and biological threats. “There is something in these [parasitic] infections that can prevent the onset of these types of diseases and our goal now is to try to distil those in molecular medicine.” Researchers hope to conduct preclinical studies (the testing stage before human trials) within the next five years. Key Findings Researchers are working to develop a new drug for type 2 diabetes by determining what therapeutic properties hookworm saliva has. Hookworms are also being studied for other purposes, such as treating gluten intolerance and coeliac disease, and protecting soldiers from biological and chemical threats. Researchers hope to conduct preclinical studies for drugs derived from hookworms within the next five years.
News 4 February 2025 Urgent calls for diabetes funding in 2025-26 Federal Budget The Diabetes Alliance has called on the Federal Government to commit to, and fund, the recommendations of the Parliament Inquiry... Continue Reading
Media releases 31 January 2025 Tasmania’s Deputy Premier gears up to support the diabetes community Tasmania’s stunning landscapes will once again play host to Pollie Pedal Tasmania 2025, a three-day cycling event to raise funds... Continue Reading
News 18 December 2024 Ozempic supply to remain limited in 2025 Ozempic supply will continue to be limited until the end of 2025, according to the latest advice from Novo Nordisk,... Continue Reading